Literature DB >> 21340308

Active pulmonary tuberculosis manifesting with idiopathic thrombocytopenic purpura: a rare presentation.

Payam Tabarsi, Muayad Aghali Merza, Majid Marjani.   

Abstract

A 17-year-old girl presented with a 3-day history of epistaxis, vaginal bleeding and petechiae over the lower extremities. The patient had been feeling unwell with productive cough, fever, chills, poor appetite and weight loss for 2 months. Laboratory findings revealed anemia and thrombocytopenia, whereas bone marrow examination was unremarkable. She was diagnosed as having idiopathic thrombocytopenic purpura (ITP) in association with active tuberculosis (TB). The patient was treated with intravenous immunoglobulin (IVIg) and corticosteroid along with anti-TB drugs. During the follow-up period there was no recurrence of thrombocytopenia or TB. It is important to consider TB in the differential diagnosis of ITP, particularly in high TB-burden areas.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21340308

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  3 in total

1.  Immune Thrombocytopenia as a Presenting Manifestation of Tuberculosis- Challenge in Resource Constraint Settings.

Authors:  Deba Prasad Dhibar; Kamal Kant Sahu; Varun Dhir; Surjit Singh
Journal:  J Clin Diagn Res       Date:  2016-10-01

2.  Immune thrombocytopenic purpura induced by intestinal tuberculosis in a liver transplant recipient.

Authors:  Renata dos Santos Lugao; Marina Pamponet Motta; Matheus Freitas Cardoso de Azevedo; Roque Gabriel Rezende de Lima; Flávia de Azevedo Abrantes; Edson Abdala; Flair José Carrilho; Daniel Ferraz de Campos Mazo
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

3.  Associations between selected immune-mediated diseases and tuberculosis: record-linkage studies.

Authors:  Sreeram V Ramagopalan; Raph Goldacre; Andrew Skingsley; Chris Conlon; Michael J Goldacre
Journal:  BMC Med       Date:  2013-04-04       Impact factor: 8.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.